MentionFox
Home › 5%+ stakes › Manufacturing (industry group 38), latest filing in August 2026
5%+ stakes

Manufacturing (industry group 38), latest filing in August 2026

31 companies with 5%+ holders, every filing linked: Aehr Test Systems, Becton Dickinson & Co, Biotricity Inc., Boston Scientific Corp, Bruker Corp, Cohu, Inc. and more. Each section is the company's full record from its filings, newest filings first within each section.

31 companies with 5%+ holders on this page (Manufacturing (industry group 38), latest filing in August 2026), each linked to its filing, starting with Aehr Test Systems, Becton Dickinson & Co, Biotricity Inc.. Free check on any of them: https://mentionfox.com/check

On this page

Aehr Test Systems

At 5% or more0
Filings10
Latest filing2026-11-06

Aehr Test Systems has 10 Schedule 13D or 13G filings on record since 2025-07-08. No holder's latest filing reports 5% or more. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Baillie Gifford & Co4.3%1,290,734SCHEDULE 13G/A, 2026-02-092025-12-31
Jane Street Group, LLC3.3%1,076,577SCHEDULE 13G/A, 2026-11-062026-09-30
Fmr LLC3.2%1,006,830SCHEDULE 13G/A, 2026-08-062026-06-30
AWM Investment Company, Inc.1.1%374,808SCHEDULE 13G/A, 2026-08-142026-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Jane Street Group, LLC01,076,57701,076,577SCHEDULE 13G/A, 2026-11-06
Jane Street Capital, LLC0982,3150982,315SCHEDULE 13G/A, 2026-11-06
Jane Street Global Trading, LLC094,262094,262SCHEDULE 13G/A, 2026-11-06
Fmr LLC1,004,56801,006,8300SCHEDULE 13G/A, 2026-08-06
Abigail P. Johnson001,006,8300SCHEDULE 13G/A, 2026-08-06
AWM Investment Company, Inc.374,8080374,8080SCHEDULE 13G/A, 2026-08-14

The latest filing identifies Aehr Test Systems by CUSIP 00760J108 and gives its principal executive office as 400 KATO TERRACE, FREMONT, CA 94539 (SCHEDULE 13G/A, 2026-11-06).

FiledHolderPercentFiling
2025-07-08Fmr LLC5%SCHEDULE 13G/A
2025-11-05Fmr LLC9%SCHEDULE 13G/A
2025-11-10Baillie Gifford & Co5.1%SCHEDULE 13G/A
2026-02-09Baillie Gifford & Co4.3%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-05-06Fmr LLC7%SCHEDULE 13G/A
2026-07-29Jane Street Group, LLC5.1%SCHEDULE 13G
2026-08-06Fmr LLC3.2%SCHEDULE 13G/A
2026-08-14AWM Investment Company, Inc.1.1%SCHEDULE 13G/A
2026-11-06Jane Street Group, LLC3.3%SCHEDULE 13G/A
DateRecordFigureOur pageSource
October 29, 2026Leadership change: Narsing Vijayrao appointed, Director—Leadership changesSource

Becton Dickinson & Co

At 5% or more4
Filings9
Latest filing2026-08-07

Becton Dickinson & Co has 9 Schedule 13D or 13G filings on record since 2025-07-07. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.51%21,397,756SCHEDULE 13G, 2026-04-292026-03-31
Vanguard Portfolio Management5.4%15,388,359SCHEDULE 13G, 2026-04-292026-03-31
State Street Corporation5.4%15,014,710SCHEDULE 13G, 2026-08-072026-06-30
First Eagle Investment Management, LLC5.1%14,138,027SCHEDULE 13G, 2026-08-062026-06-30
T. Rowe Price Investment Management, Inc.3.4%9,673,586SCHEDULE 13G/A, 2026-05-152026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Portfolio Management71,117015,388,3590SCHEDULE 13G, 2026-04-29
State Street Corporation09,911,498015,000,067SCHEDULE 13G, 2026-08-07
First Eagle Investment Management, LLC12,845,517014,138,0270SCHEDULE 13G, 2026-08-06
T. Rowe Price Investment Management, Inc.9,066,40109,673,5860SCHEDULE 13G/A, 2026-05-15

The latest filing identifies Becton Dickinson & Co by CUSIP 075887109 and gives its principal executive office as 1 BECTON DRIVE, FRANKLIN LAKES, NJ 07417 (SCHEDULE 13G, 2026-08-07).

FiledHolderPercentFiling
2025-07-07The Vanguard Group11.27%SCHEDULE 13G/A
2025-08-14T. Rowe Price Investment Management, Inc.5.6%SCHEDULE 13G
2026-01-30The Vanguard Group12.85%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management7.51%SCHEDULE 13G
2026-04-29Vanguard Portfolio Management5.4%SCHEDULE 13G
2026-05-15T. Rowe Price Investment Management, Inc.3.4%SCHEDULE 13G/A
2026-08-06First Eagle Investment Management, LLC5.1%SCHEDULE 13G
2026-08-07State Street Corporation5.4%SCHEDULE 13G
DateRecordFigureOur pageSource
July 22, 2026Leadership change: Michael D. Garrison departs, Executive Vice President—Leadership changesSource
May 7, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
April 9, 2026Leadership change: Richard E. Byrd departs, Executive Vice President—Leadership changesSource

Biotricity Inc.

At 5% or more1
Filings5
Latest filing2026-08-14

Biotricity Inc. has 5 Schedule 13D or 13G filings on record since 2025-08-12. 1 holder's latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Ionic Ventures, LLC9.9%3,241,770SCHEDULE 13G/A, 2026-08-142026-06-30
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Ionic Ventures, LLC03,241,77003,241,770SCHEDULE 13G/A, 2026-08-14
Ionic Management, LLC03,241,77003,241,770SCHEDULE 13G/A, 2026-08-14
Brendan O'Neil03,241,77003,241,770SCHEDULE 13G/A, 2026-08-14
Keith Coulston03,241,77003,241,770SCHEDULE 13G/A, 2026-08-14

The latest filing identifies Biotricity Inc. by CUSIP 09074H203 and gives its principal executive office as 203 Redwood Shores Parkway, Suite 600, Redwood City, CA 94065 (SCHEDULE 13G/A, 2026-08-14).

FiledHolderPercentFiling
2025-08-12Ionic Ventures, LLC9.9%SCHEDULE 13G/A
2025-11-14Ionic Ventures, LLC9.9%SCHEDULE 13G/A
2026-02-04Ionic Ventures, LLC9.9%SCHEDULE 13G/A
2026-05-12Ionic Ventures, LLC9.9%SCHEDULE 13G/A
2026-08-14Ionic Ventures, LLC9.9%SCHEDULE 13G/A
DateRecordFigureOur pageSource
September 28, 2026Leadership change: Jainal Bhuiyan departs, Director—Leadership changesSource

Boston Scientific Corp

At 5% or more1
Filings5
Latest filing2026-08-06

Boston Scientific Corp has 5 Schedule 13D or 13G filings on record since 2025-08-06. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Layoffs on record: 1 filing or notice, latest 2026-07-27 (layoff filings and notices).

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.47%111,127,205SCHEDULE 13G, 2026-04-292026-03-31
Fmr LLC3.1%46,378,259SCHEDULE 13G/A, 2026-08-062026-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management14,715,6370111,127,2050SCHEDULE 13G, 2026-04-29
Fmr LLC39,968,563046,378,2590SCHEDULE 13G/A, 2026-08-06
Abigail P. Johnson0046,378,2590SCHEDULE 13G/A, 2026-08-06
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Boston Scientific Corp by CUSIP 101137107 and gives its principal executive office as 300 Boston Scientific Way, Marlborough, MA 01752-1234 (SCHEDULE 13G/A, 2026-08-06).

FiledHolderPercentFiling
2025-08-06Fmr LLC7.5%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management7.47%SCHEDULE 13G
2026-05-06Fmr LLC5.1%SCHEDULE 13G/A
2026-08-06Fmr LLC3.1%SCHEDULE 13G/A
DateRecordFigureOur pageSource
October 7, 2026Leadership change: Joe Fitzgerald appointed, Chief Operating Officer, and 2 more—Leadership changesSource
September 23, 2026Leadership change: Arthur C. Butcher departs, Executive Vice President—Leadership changesSource

Bruker Corp

At 5% or more2
Filings12
Latest filing2026-08-06

Bruker Corp has 12 Schedule 13D or 13G filings on record since 2025-08-06. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Fmr LLC15%23,296,466SCHEDULE 13G/A, 2026-08-062026-06-30
Orbis Investment Management Ltd11.1%16,852,868SCHEDULE 13G/A, 2026-05-152026-03-31
T. Rowe Price Investment Management, Inc.3%4,594,398SCHEDULE 13G/A, 2026-02-172025-12-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Fmr LLC17,974,598023,296,4660SCHEDULE 13G/A, 2026-08-06
Abigail P. Johnson0023,296,4660SCHEDULE 13G/A, 2026-08-06
Orbis Investment Management Ltd16,852,868016,852,8680SCHEDULE 13G/A, 2026-05-15
Allan Gray Australia Pty Ltd28,322028,3220SCHEDULE 13G/A, 2026-05-15
Orbis Investment Management (U.S.) L.P.1,058,88601,058,8860SCHEDULE 13G/A, 2026-05-15
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Bruker Corp by CUSIP 116794108 and gives its principal executive office as 40 Manning Rd, Billerica, MA 01821 (SCHEDULE 13G/A, 2026-08-06).

FiledHolderPercentFiling
2025-08-06Fmr LLC5.5%SCHEDULE 13G/A
2025-08-14T. Rowe Price Investment Management, Inc.7.5%SCHEDULE 13G/A
2025-10-07Fmr LLC11%SCHEDULE 13G/A
2025-11-14Orbis Investment Management Ltd8.8%SCHEDULE 13G
2025-11-14T. Rowe Price Investment Management, Inc.5.1%SCHEDULE 13G/A
2026-02-17Orbis Investment Management Ltd9.3%SCHEDULE 13G/A
2026-02-17T. Rowe Price Investment Management, Inc.3%SCHEDULE 13G/A
2026-03-06Orbis Investment Management Ltd10%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-05-06Fmr LLC12.4%SCHEDULE 13G/A
2026-05-15Orbis Investment Management Ltd11.1%SCHEDULE 13G/A
2026-08-06Fmr LLC15%SCHEDULE 13G/A
DateRecordFigureOur pageSource
April 10, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
April 1, 2026Leadership change: Thierry L. Bernard appointed, Director, and 1 more—Leadership changesSource

Cohu, Inc.

At 5% or more3
Filings9
Latest filing2026-08-12

Cohu, Inc. has 9 Schedule 13D or 13G filings on record since 2025-07-17. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.14.7%6,848,670SCHEDULE 13G/A, 2025-07-172025-06-30
Capital World Investors5.8%2,757,413SCHEDULE 13G, 2026-08-122026-06-30
Vanguard Capital Management5.01%2,365,526SCHEDULE 13G, 2026-07-312026-06-30
Victory Capital Management, Inc.4.91%2,334,824SCHEDULE 13G/A, 2026-05-122026-03-31
Dimensional Fund Advisors LP4%1,849,027SCHEDULE 13G/A, 2026-01-212025-12-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Capital World Investors2,757,41302,757,4130SCHEDULE 13G, 2026-08-12
Vanguard Capital Management358,18902,365,5260SCHEDULE 13G, 2026-07-31
Victory Capital Management, Inc.2,313,24902,334,8240SCHEDULE 13G/A, 2026-05-12
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Cohu, Inc. by CUSIP 192576106 and gives its principal executive office as 17087 Via Del Campo, San Diego (SCHEDULE 13G, 2026-08-12).

FiledHolderPercentFiling
2025-07-17BlackRock, Inc.14.7%SCHEDULE 13G/A
2025-08-08Victory Capital Management, Inc.8.94%SCHEDULE 13G/A
2025-10-09Dimensional Fund Advisors LP5.1%SCHEDULE 13G/A
2025-10-30Victory Capital Management, Inc.6.3%SCHEDULE 13G/A
2026-01-21Dimensional Fund Advisors LP4%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-05-12Victory Capital Management, Inc.4.91%SCHEDULE 13G/A
2026-07-31Vanguard Capital Management5.01%SCHEDULE 13G
2026-08-12Capital World Investors5.8%SCHEDULE 13G

Cytek Biosciences, Inc.

At 5% or more4
Filings11
Latest filing2026-11-03

Cytek Biosciences, Inc. has 11 Schedule 13D or 13G filings on record since 2025-07-18. 4 holders' latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.7.2%9,356,551SCHEDULE 13G/A, 2026-07-082026-06-30
Boston Partners5.91%7,635,145SCHEDULE 13G, 2026-08-042026-06-30
Millennium Management LLC5.6%7,281,488SCHEDULE 13G/A, 2026-11-032026-09-30
Topline Capital Management, LLC5.3%6,780,847SCHEDULE 13G, 2025-11-172025-09-25
Brown Capital Management, LLC3.9%4,958,016SCHEDULE 13G/A, 2025-11-122025-09-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.9,228,73709,356,5510SCHEDULE 13G/A, 2026-07-08
Boston Partners7,635,14507,635,1450SCHEDULE 13G, 2026-08-04
Integrated Core Strategies (US) LLC05,870,95405,870,954SCHEDULE 13G/A, 2026-11-03
Millennium Management LLC07,281,48807,281,488SCHEDULE 13G/A, 2026-11-03
Millennium Group Management LLC07,281,48807,281,488SCHEDULE 13G/A, 2026-11-03
Israel A. Englander07,281,48807,281,488SCHEDULE 13G/A, 2026-11-03

The latest filing identifies Cytek Biosciences, Inc. by CUSIP 23285D109 and gives its principal executive office as 47215 Lakeview Boulevard, Fremont, CA 94538 (SCHEDULE 13G/A, 2026-11-03).

FiledHolderPercentFiling
2025-07-18BlackRock, Inc.13.1%SCHEDULE 13G/A
2025-07-29The Vanguard Group6.13%SCHEDULE 13G/A
2025-11-12Brown Capital Management, LLC3.9%SCHEDULE 13G/A
2025-11-17Topline Capital Management, LLC5.3%SCHEDULE 13G
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-09Millennium Management LLC5.2%SCHEDULE 13G
2026-05-18Millennium Management LLC6.1%SCHEDULE 13G/A
2026-07-08BlackRock, Inc.7.2%SCHEDULE 13G/A
2026-08-04Boston Partners5.91%SCHEDULE 13G
2026-08-06Millennium Management LLC7.2%SCHEDULE 13G/A
2026-11-03Millennium Management LLC5.6%SCHEDULE 13G/A
DateRecordFigureOur pageSource
June 25, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
June 2, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Ge Healthcare Technologies Inc.

At 5% or more2
Filings9
Latest filing2026-08-07

Ge Healthcare Technologies Inc. has 9 Schedule 13D or 13G filings on record since 2025-08-13. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Dodge & Cox10.5%47,334,058SCHEDULE 13G/A, 2026-08-072026-07-31
Vanguard Capital Management7.31%33,370,111SCHEDULE 13G, 2026-04-292026-03-31
Capital Research Global Investors4.6%21,114,633SCHEDULE 13G/A, 2026-05-142026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Dodge & Cox44,872,703047,334,0580SCHEDULE 13G/A, 2026-08-07
Capital Research Global Investors21,106,720021,114,6330SCHEDULE 13G/A, 2026-05-14

The latest filing identifies Ge Healthcare Technologies Inc. by CUSIP 36266G107 and gives its principal executive office as 500 W. Monroe Street, Chicago, IL 60661 (SCHEDULE 13G/A, 2026-08-07).

FiledHolderPercentFiling
2025-08-13Dodge & Cox5.1%SCHEDULE 13G
2025-11-13Capital Research Global Investors5.5%SCHEDULE 13G
2026-02-13Dodge & Cox6.9%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management7.31%SCHEDULE 13G
2026-05-14Dodge & Cox6.9%SCHEDULE 13G/A
2026-05-14Capital Research Global Investors4.6%SCHEDULE 13G/A
2026-08-07Dodge & Cox8.3%SCHEDULE 13G/A
2026-08-07Dodge & Cox10.5%SCHEDULE 13G/A
DateRecordFigureOur pageSource
November 5, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
October 28, 2026Leadership change: Jeannette Bankes departs, President—Leadership changesSource
September 22, 2026Leadership change: Pascal Desroches appointed, Director—Leadership changesSource
August 18, 2026Leadership change: William K. Grogan appointed, Chief Financial Officer—Leadership changesSource
July 23, 2026Leadership change: George Newcomb appointed, Chief Financial Officer—Leadership changesSource

Icecure Medical Ltd.

At 5% or more2
Filings2
Latest filing2026-08-14

Icecure Medical Ltd. has 2 Schedule 13D or 13G filings on record since 2026-03-27. 2 holders' latest filing reports 5% or more of ordinary shares, no par value. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Mr. Li Haixiang45.8%35,846,597SCHEDULE 13D/A, 2026-03-272026-03-17
Armistice Capital, LLC9.99%300,332SCHEDULE 13G, 2026-08-142026-06-30
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Mr. Li Haixiang035,846,597035,846,597SCHEDULE 13D/A, 2026-03-27
Epoch Partner Investments Limited035,846,597035,846,597SCHEDULE 13D/A, 2026-03-27
Armistice Capital, LLC0300,3320300,332SCHEDULE 13G, 2026-08-14
Steven Boyd0300,3320300,332SCHEDULE 13G, 2026-08-14

The latest filing identifies Icecure Medical Ltd. by CUSIP M53071201 and gives its principal executive office as 7 Ha'Eshel St., PO Box 3163, Caesarea (SCHEDULE 13G, 2026-08-14).

This item is not being amended by this Schedule 13D/A.Mr. Li Haixiang, SCHEDULE 13D/A, 2026-03-27

Mr. Li Haixiang

This item is not being amended by this Schedule 13D/A.Item 4 of the SCHEDULE 13D/A filed 2026-03-27
FiledHolderPercentFiling
2026-03-27Mr. Li Haixiang45.8%SCHEDULE 13D/A
2026-08-14Armistice Capital, LLC9.99%SCHEDULE 13G
DateRecordFigureOur pageSource
June 25, 2026Form D, private offering$16.50M soldForm D pageSource
March 31, 2026Form D, private offering$4M soldForm D pageSource

Icu Medical Inc

At 5% or more4
Filings7
Latest filing2026-08-14

Icu Medical Inc has 7 Schedule 13D or 13G filings on record since 2025-08-14. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
JANUS HENDERSON GROUP Ltd.11.1%2,781,621SCHEDULE 13G/A, 2026-08-132026-06-30
Vanguard Portfolio Management5.82%1,455,765SCHEDULE 13G, 2026-04-292026-03-31
Vanguard Capital Management5.19%1,298,459SCHEDULE 13G, 2026-04-302026-03-31
Fuller & Thaler Asset Management, Inc.5.19%1,298,127SCHEDULE 13G/A, 2026-08-142026-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
JANUS HENDERSON GROUP Ltd.02,781,62102,781,621SCHEDULE 13G/A, 2026-08-13
Vanguard Capital Management186,58401,298,4590SCHEDULE 13G, 2026-04-30
Fuller & Thaler Asset Management, Inc.1,276,82001,298,1270SCHEDULE 13G/A, 2026-08-14

The latest filing identifies Icu Medical Inc by CUSIP 44930G107 and gives its principal executive office as 951 CALLE AMANECER, SAN CLEMENTE, CA 92763-6212 (SCHEDULE 13G/A, 2026-08-14).

FiledHolderPercentFiling
2025-08-14Janus Henderson Group Plc10%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management5.82%SCHEDULE 13G
2026-04-30Vanguard Capital Management5.19%SCHEDULE 13G
2026-05-13Fuller & Thaler Asset Management, Inc.4.94%SCHEDULE 13G/A
2026-08-13JANUS HENDERSON GROUP Ltd.11.1%SCHEDULE 13G/A
2026-08-14Fuller & Thaler Asset Management, Inc.5.19%SCHEDULE 13G/A

Integra Lifesciences Holdings Corp

At 5% or more3
Filings9
Latest filing2026-08-13

Integra Lifesciences Holdings Corp has 9 Schedule 13D or 13G filings on record since 2025-07-09. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.13.2%10,282,705SCHEDULE 13G/A, 2025-07-172025-06-30
Rubric Capital Management LP9.46%7,353,934SCHEDULE 13G/A, 2025-07-092025-06-30
Vanguard Portfolio Management5.02%3,912,816SCHEDULE 13G, 2026-07-312026-06-30
Fuller & Thaler Asset Management, Inc.4.67%3,636,360SCHEDULE 13G/A, 2026-02-172025-12-31
Invesco Ltd.4.5%3,490,908SCHEDULE 13G/A, 2025-11-062025-09-30
Morgan Stanley4.3%3,379,401SCHEDULE 13G/A, 2025-08-052025-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Paradigm Capital Management IncSCHEDULE 13G/A, 2026-08-132026-03-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Portfolio Management169,72303,912,8160SCHEDULE 13G, 2026-07-31
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Integra Lifesciences Holdings Corp by CUSIP 457985208 and gives its principal executive office as 1100 CAMPUS ROAD, PRINCETON, NJ 08540 (SCHEDULE 13G/A, 2026-08-13).

FiledHolderPercentFiling
2025-07-09Rubric Capital Management LP9.46%SCHEDULE 13G/A
2025-07-17BlackRock, Inc.13.2%SCHEDULE 13G/A
2025-08-05Morgan Stanley4.3%SCHEDULE 13G/A
2025-11-06Invesco Ltd.4.5%SCHEDULE 13G/A
2026-02-17Fuller & Thaler Asset Management, Inc.4.67%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-05-15Paradigm Capital Management Inc5.2%SCHEDULE 13G
2026-07-31Vanguard Portfolio Management5.02%SCHEDULE 13G
2026-08-13Paradigm Capital Management IncSCHEDULE 13G/A
DateRecordFigureOur pageSource
May 5, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Intelligent Bio Solutions Inc.

At 5% or more2
Filings3
Latest filing2026-08-14

Intelligent Bio Solutions Inc. has 3 Schedule 13D or 13G filings on record since 2025-11-14. 2 holders' latest filing reports 5% or more of common stock, $0.01 par value. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Alyeska Investment Group, L.P.9.99%944,310SCHEDULE 13G/A, 2025-11-142025-09-30
Armistice Capital, LLC5.91%141,397SCHEDULE 13G/A, 2026-08-142026-06-30
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Alyeska Investment Group, L.P.0944,3100944,310SCHEDULE 13G/A, 2025-11-14
Alyeska Fund GP, LLC0944,3100944,310SCHEDULE 13G/A, 2025-11-14
Anand Parekh0944,3100944,310SCHEDULE 13G/A, 2025-11-14
Armistice Capital, LLC0141,3970141,397SCHEDULE 13G/A, 2026-08-14
Steven Boyd0141,3970141,397SCHEDULE 13G/A, 2026-08-14

The latest filing identifies Intelligent Bio Solutions Inc. by CUSIP 36151G709 and gives its principal executive office as 135 West, 41st Street, 5th Floor, New York, NY 10036 (SCHEDULE 13G/A, 2026-08-14).

FiledHolderPercentFiling
2025-11-14Alyeska Investment Group, L.P.9.99%SCHEDULE 13G/A
2026-05-15Armistice Capital, LLC9.99%SCHEDULE 13G
2026-08-14Armistice Capital, LLC5.91%SCHEDULE 13G/A
DateRecordFigureOur pageSource
September 14, 2026Form D, private offering$4.98M soldForm D pageSource
January 13, 2026Form D, private offering$9.98M soldForm D pageSource
August 11, 2025Form D, private offering$3.84M soldForm D pageSource

Intest Corp

At 5% or more1
Filings7
Latest filing2026-08-07

Intest Corp has 7 Schedule 13D or 13G filings on record since 2025-08-07. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.6.6%824,291SCHEDULE 13G, 2026-07-282026-06-30
Vanguard Capital Management4.69%589,953SCHEDULE 13G/A, 2026-07-312026-06-30
Thomas A. Satterfield, Jr.4.4%550,000SCHEDULE 13G/A, 2026-04-292026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Askeladden Capital Management LLC0%0SCHEDULE 13G/A, 2026-08-072025-04-11
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.814,1080824,2910SCHEDULE 13G, 2026-07-28
Vanguard Capital Management79,8480589,9530SCHEDULE 13G/A, 2026-07-31
Askeladden Capital Management LLC0000SCHEDULE 13G/A, 2026-08-07
Samir Patel0000SCHEDULE 13G/A, 2026-08-07

The latest filing identifies Intest Corp by CUSIP 461147100 and gives its principal executive office as 804 EAST GATE DR., SUITE 200, MT. LAUREL, NJ 08054 (SCHEDULE 13G/A, 2026-08-07).

The percentage calculated in Item 11 is based on 12,564,657 shares of Common Stock outstanding as of April 30, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 and as filed with the SEC on May 11, 2026.Askeladden Capital Management LLC, SCHEDULE 13G/A, 2026-08-07
FiledHolderPercentFiling
2025-08-07Thomas A. Satterfield, Jr.8%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Thomas A. Satterfield, Jr.4.4%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management5.45%SCHEDULE 13G
2026-07-28BlackRock, Inc.6.6%SCHEDULE 13G
2026-07-31Vanguard Capital Management4.69%SCHEDULE 13G/A
2026-08-07Askeladden Capital Management LLC0%SCHEDULE 13G/A
DateRecordFigureOur pageSource
April 10, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
April 2, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Keysight Technologies In

At 5% or more3
Filings5
Latest filing2026-08-14

Keysight Technologies In has 5 Schedule 13D or 13G filings on record since 2026-03-27. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.5%12,862,933SCHEDULE 13G, 2026-04-302026-03-31
T. Rowe Price Associates, Inc.5.6%9,620,744SCHEDULE 13G/A, 2026-08-142026-06-30
Vanguard Portfolio Management5.03%8,638,464SCHEDULE 13G, 2026-04-292026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management1,707,458012,862,9330SCHEDULE 13G, 2026-04-30
T. Rowe Price Associates, Inc.9,365,64409,620,7440SCHEDULE 13G/A, 2026-08-14
Vanguard Portfolio Management20,82108,638,4640SCHEDULE 13G, 2026-04-29

The latest filing identifies Keysight Technologies In by CUSIP 49338L103 and gives its principal executive office as 1400 FOUNTAINGROVE PARKWAY, SANTA ROSA, CA 95403 (SCHEDULE 13G/A, 2026-08-14).

FiledHolderPercentFiling
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management5.03%SCHEDULE 13G
2026-04-30Vanguard Capital Management7.5%SCHEDULE 13G
2026-05-15T. Rowe Price Associates, Inc.8.7%SCHEDULE 13G/A
2026-08-14T. Rowe Price Associates, Inc.5.6%SCHEDULE 13G/A
DateRecordFigureOur pageSource
November 2, 2026Leadership change: Jason Kary appointed, Chief Financial Officer, and 1 more—Leadership changesSource
August 26, 2026Leadership change: Scott Reese appointed, and 1 more—Leadership changesSource

L3Harris Technologies, Inc.

At 5% or more3
Filings6
Latest filing2026-08-12

L3Harris Technologies, Inc. has 6 Schedule 13D or 13G filings on record since 2025-08-14. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.8.3%15,474,104SCHEDULE 13G/A, 2026-07-292026-06-30
Vanguard Capital Management7.49%13,994,852SCHEDULE 13G, 2026-04-302026-03-31
Vanguard Portfolio Management5.12%9,573,507SCHEDULE 13G, 2026-04-292026-03-31
T. Rowe Price Associates, Inc.4.6%8,623,209SCHEDULE 13G/A, 2025-08-142025-06-30
Capital World Investors3.6%6,767,234SCHEDULE 13G/A, 2026-08-122026-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.14,772,621015,474,1040SCHEDULE 13G/A, 2026-07-29
Vanguard Capital Management1,859,616013,994,8520SCHEDULE 13G, 2026-04-30
Vanguard Portfolio Management23,56209,573,5070SCHEDULE 13G, 2026-04-29
Capital World Investors6,685,76906,767,2340SCHEDULE 13G/A, 2026-08-12

The latest filing identifies L3Harris Technologies, Inc. by CUSIP 502431109 and gives its principal executive office as 1025 West NASA Boulevard, Melbourne (SCHEDULE 13G/A, 2026-08-12).

FiledHolderPercentFiling
2025-08-14T. Rowe Price Associates, Inc.4.6%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management5.12%SCHEDULE 13G
2026-04-30Vanguard Capital Management7.49%SCHEDULE 13G
2026-07-29BlackRock, Inc.8.3%SCHEDULE 13G/A
2026-08-12Capital World Investors3.6%SCHEDULE 13G/A
DateRecordFigureOur pageSource
October 22, 2026Leadership change: Kimberly Fields appointed, Director—Leadership changesSource
August 17, 2026Leadership change: Sam Mehta appointed—Leadership changesSource
July 24, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Livanova Plc

At 5% or more3
Filings7
Latest filing2026-11-05

Livanova Plc has 7 Schedule 13D or 13G filings on record since 2025-07-18. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.12.7%6,922,335SCHEDULE 13G/A, 2025-07-182025-06-30
Primecap Management Co7.74%4,224,852SCHEDULE 13G/A, 2026-02-122025-12-31
Fmr LLC7.1%3,897,920SCHEDULE 13G/A, 2026-11-052026-09-30
Millennium Management LLC4.4%2,438,671SCHEDULE 13G/A, 2026-04-302026-03-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Primecap Management Co4,203,36204,224,8520SCHEDULE 13G/A, 2026-02-12
Fmr LLC3,896,80503,897,9200SCHEDULE 13G/A, 2026-11-05
Abigail P. Johnson003,897,9200SCHEDULE 13G/A, 2026-11-05
Integrated Core Strategies (US) LLC02,321,06702,321,067SCHEDULE 13G/A, 2026-04-30
Millennium Management LLC02,438,67102,438,671SCHEDULE 13G/A, 2026-04-30
Millennium Group Management LLC02,438,67102,438,671SCHEDULE 13G/A, 2026-04-30
Israel A. Englander02,438,67102,438,671SCHEDULE 13G/A, 2026-04-30

The latest filing identifies Livanova Plc by CUSIP G5509L101 and gives its principal executive office as 5220 VALIANT COURT, GLOUCESTER BUSINESS PARK, GLOUCESTER (SCHEDULE 13G/A, 2026-11-05).

FiledHolderPercentFiling
2025-07-18BlackRock, Inc.12.7%SCHEDULE 13G/A
2025-11-06Millennium Management LLC5.4%SCHEDULE 13G/A
2026-02-09Millennium Management LLC6.4%SCHEDULE 13G/A
2026-02-12Primecap Management Co7.74%SCHEDULE 13G/A
2026-04-30Millennium Management LLC4.4%SCHEDULE 13G/A
2026-08-06Fmr LLC5.8%SCHEDULE 13G
2026-11-05Fmr LLC7.1%SCHEDULE 13G/A

Mettler-Toledo International Inc.

At 5% or more3
Filings5
Latest filing2026-08-12

Mettler-Toledo International Inc. has 5 Schedule 13D or 13G filings on record since 2026-02-13. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Capital International Investors7.9%1,595,726SCHEDULE 13G/A, 2026-08-122026-06-30
Vanguard Capital Management7.53%1,525,553SCHEDULE 13G, 2026-04-302026-03-31
Vanguard Portfolio Management5.01%1,012,777SCHEDULE 13G, 2026-07-312026-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Capital International Investors1,587,09801,595,7260SCHEDULE 13G/A, 2026-08-12
Vanguard Capital Management203,69901,525,5530SCHEDULE 13G, 2026-04-30
Vanguard Portfolio Management2,28701,012,7770SCHEDULE 13G, 2026-07-31
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Mettler-Toledo International Inc. by CUSIP 592688105 and gives its principal executive office as 1900 POLARIS PARKWAY, COLUMBUS (SCHEDULE 13G/A, 2026-08-12).

FiledHolderPercentFiling
2026-02-13Capital International Investors5%SCHEDULE 13G
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management7.53%SCHEDULE 13G
2026-07-31Vanguard Portfolio Management5.01%SCHEDULE 13G
2026-08-12Capital International Investors7.9%SCHEDULE 13G/A
DateRecordFigureOur pageSource
August 3, 2026Leadership change: Natalia Shuman appointed, Director—Leadership changesSource
May 13, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Northrop Grumman Corp.

At 5% or more1
Filings5
Latest filing2026-08-12

Northrop Grumman Corp. has 5 Schedule 13D or 13G filings on record since 2025-08-13. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.22%10,248,540SCHEDULE 13G, 2026-04-302026-03-31
Capital International Investors4.3%6,044,489SCHEDULE 13G/A, 2026-08-122026-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management1,299,313010,248,5400SCHEDULE 13G, 2026-04-30
Capital International Investors5,851,52206,044,4890SCHEDULE 13G/A, 2026-08-12
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Northrop Grumman Corp. by CUSIP 666807102 and gives its principal executive office as 2980 FAIRVIEW PARK DRIVE, C/O NORTHROP GRUMMAN CORP, FALLS CHURCH (SCHEDULE 13G/A, 2026-08-12).

FiledHolderPercentFiling
2025-08-13Capital International Investors8.6%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management7.22%SCHEDULE 13G
2026-05-14Capital International Investors5.2%SCHEDULE 13G/A
2026-08-12Capital International Investors4.3%SCHEDULE 13G/A

Penumbra Inc

At 5% or more1
Filings6
Latest filing2026-11-06

Penumbra Inc has 6 Schedule 13D or 13G filings on record since 2026-02-05. 1 holder's latest filing reports 5% or more of common-stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management5.07%1,990,629SCHEDULE 13G, 2026-04-302026-03-31
Barclays PLC4.82%1,901,646SCHEDULE 13G/A, 2026-11-062026-09-30
Fmr LLC4.7%1,826,862SCHEDULE 13G/A, 2026-02-062026-01-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management296,14101,990,6290SCHEDULE 13G, 2026-04-30
Barclays PLC1,901,554921,901,55492SCHEDULE 13G/A, 2026-11-06
Fmr LLC1,822,61801,826,8620SCHEDULE 13G/A, 2026-02-06
Abigail P. Johnson001,826,8620SCHEDULE 13G/A, 2026-02-06
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Penumbra Inc by CUSIP 70975L107 and gives its principal executive office as One Penumbra Place, Alameda, CA 94502 (SCHEDULE 13G/A, 2026-11-06).

FiledHolderPercentFiling
2026-02-05Fmr LLC13%SCHEDULE 13G/A
2026-02-06Fmr LLC4.7%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management5.07%SCHEDULE 13G
2026-08-13Barclays PLC5.95%SCHEDULE 13G
2026-11-06Barclays PLC4.82%SCHEDULE 13G/A

Polyrizon Ltd.

At 5% or more1
Filings6
Latest filing2026-08-14

Polyrizon Ltd. has 6 Schedule 13D or 13G filings on record since 2025-12-12. 1 holder's latest filing reports 5% or more of ordinary shares. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
MMCAP International Inc. SPC9.6%199,470SCHEDULE 13G/A, 2026-08-142026-06-30
Eli Zamir0%0SCHEDULE 13G, 2026-03-162025-12-31
L.I.A. Pure Capital Ltd.0%0SCHEDULE 13G/A, 2026-03-092025-12-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
MMCAP International Inc. SPC0199,4700199,470SCHEDULE 13G/A, 2026-08-14
MM Asset Management Inc.0199,4700199,470SCHEDULE 13G/A, 2026-08-14
Eli Zamir0000SCHEDULE 13G, 2026-03-16
L.I.A. Pure Capital Ltd.0000SCHEDULE 13G/A, 2026-03-09

The latest filing identifies Polyrizon Ltd. by CUSIP M79549206 and gives its principal executive office as 8 Ha-Pnina Street, Raanana (SCHEDULE 13G/A, 2026-08-14).

FiledHolderPercentFiling
2025-12-12Eli Zamir9.99%SCHEDULE 13G
2025-12-12L.I.A. Pure Capital Ltd.9.99%SCHEDULE 13G
2026-03-09L.I.A. Pure Capital Ltd.0%SCHEDULE 13G/A
2026-03-16Eli Zamir0%SCHEDULE 13G
2026-04-28MMCAP International Inc. SPC7.3%SCHEDULE 13G
2026-08-14MMCAP International Inc. SPC9.6%SCHEDULE 13G/A
DateRecordFigureOur pageSource
September 10, 2026Form D, private offering$4M soldForm D pageSource
April 23, 2026Form D, private offering$3.50M soldForm D pageSource

Ralliant Corporation

At 5% or more5
Filings11
Latest filing2026-08-13

Ralliant Corporation has 11 Schedule 13D or 13G filings on record since 2025-07-02. 5 holders' latest filing reports 5% or more of common stock, par value $0.01 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Dodge & Cox12.3%13,747,551SCHEDULE 13G/A, 2026-05-142026-03-31
BlackRock, Inc.11.2%12,646,395SCHEDULE 13G/A, 2025-10-172025-09-30
Vanguard Portfolio Management7.57%8,468,985SCHEDULE 13G, 2026-04-292026-03-31
Vanguard Capital Management5.3%5,926,675SCHEDULE 13G, 2026-04-302026-03-31
Millennium Management LLC5.1%5,610,784SCHEDULE 13G, 2026-08-132026-08-06
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Dodge & Cox12,974,437013,747,5510SCHEDULE 13G/A, 2026-05-14
Vanguard Portfolio Management13,73208,468,9850SCHEDULE 13G, 2026-04-29
Vanguard Capital Management859,42305,926,6750SCHEDULE 13G, 2026-04-30
Millennium Management LLC05,605,55805,610,784SCHEDULE 13G, 2026-08-13
Millennium Group Management LLC05,605,55805,610,784SCHEDULE 13G, 2026-08-13
Israel A. Englander05,605,55805,610,784SCHEDULE 13G, 2026-08-13

The latest filing identifies Ralliant Corporation by CUSIP 750940108 and gives its principal executive office as 4114 Center at North Hills Street, Suite 400, Raleigh, NC 27609 (SCHEDULE 13G, 2026-08-13).

FiledHolderPercentFiling
2025-07-02BlackRock, Inc.14.5%SCHEDULE 13G
2025-07-07The Vanguard Group11.65%SCHEDULE 13G
2025-08-13Dodge & Cox9.6%SCHEDULE 13G
2025-10-17BlackRock, Inc.11.2%SCHEDULE 13G/A
2025-10-30The Vanguard Group12.94%SCHEDULE 13G/A
2025-11-06Dodge & Cox10.7%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management7.57%SCHEDULE 13G
2026-04-30Vanguard Capital Management5.3%SCHEDULE 13G
2026-05-14Dodge & Cox12.3%SCHEDULE 13G/A
2026-08-13Millennium Management LLC5.1%SCHEDULE 13G

Resmed Inc

At 5% or more3
Filings5
Latest filing2026-08-07

Resmed Inc has 5 Schedule 13D or 13G filings on record since 2025-10-30. 3 holders' latest filing reports 5% or more of ordinary shares. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management8.21%11,961,706SCHEDULE 13G, 2026-04-292026-03-31
AustralianSuper Pty Ltd5.7%8,276,381SCHEDULE 13G, 2026-08-072026-06-30
Vanguard Portfolio Management5.41%7,886,489SCHEDULE 13G, 2026-04-292026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management2,495,290011,961,7060SCHEDULE 13G, 2026-04-29
AustralianSuper Pty Ltd8,276,38108,276,3810SCHEDULE 13G, 2026-08-07
Vanguard Portfolio Management22,56707,886,4890SCHEDULE 13G, 2026-04-29
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Resmed Inc by CUSIP 761152107 and gives its principal executive office as 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA 92123 (SCHEDULE 13G, 2026-08-07).

FiledHolderPercentFiling
2025-10-30The Vanguard Group13.66%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management8.21%SCHEDULE 13G
2026-04-29Vanguard Portfolio Management5.41%SCHEDULE 13G
2026-08-07AustralianSuper Pty Ltd5.7%SCHEDULE 13G
DateRecordFigureOur pageSource
August 17, 2026Leadership change: Ronald Taylor departs, Director—Leadership changesSource
April 30, 2026Leadership change: Brett Sandercock departs, Chief Financial Officer, and 2 more—Leadership changesSource

Roper Technolgies, Inc.

At 5% or more5
Filings9
Latest filing2026-08-14

Roper Technolgies, Inc. has 9 Schedule 13D or 13G filings on record since 2025-08-14. 5 holders' latest filing reports 5% or more of common stock, $0.01 par value. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
The WindAcre Partnership LLC8.55%8,630,200SCHEDULE 13G/A, 2026-08-142026-06-30
Vanguard Capital Management7.63%7,863,588SCHEDULE 13G, 2026-04-302026-03-31
Dodge & Cox7%7,060,583SCHEDULE 13G, 2026-08-132026-06-30
Vanguard Portfolio Management5.67%5,839,874SCHEDULE 13G, 2026-04-292026-03-31
State Street Corporation5.1%5,164,186SCHEDULE 13G, 2026-08-072026-06-30
T. Rowe Price Associates, Inc.4%4,329,407SCHEDULE 13G/A, 2025-08-142025-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
The WindAcre Partnership LLC08,630,20008,630,200SCHEDULE 13G/A, 2026-08-14
The WindAcre Partnership Master Fund, LP08,630,20008,630,200SCHEDULE 13G/A, 2026-08-14
Snehal Rajnikant Amin08,630,20008,630,200SCHEDULE 13G/A, 2026-08-14
Dodge & Cox6,671,03307,060,5830SCHEDULE 13G, 2026-08-13
State Street Corporation03,306,25805,158,880SCHEDULE 13G, 2026-08-07

The latest filing identifies Roper Technolgies, Inc. by CUSIP 776696106 and gives its principal executive office as 6496 University Parkway, Sarasota, FL 34240 (SCHEDULE 13G/A, 2026-08-14).

FiledHolderPercentFiling
2025-08-14T. Rowe Price Associates, Inc.4%SCHEDULE 13G/A
2026-01-30The Vanguard Group11.59%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management5.67%SCHEDULE 13G
2026-04-30Vanguard Capital Management7.63%SCHEDULE 13G
2026-05-15The WindAcre Partnership LLC7.28%SCHEDULE 13G
2026-08-07State Street Corporation5.1%SCHEDULE 13G
2026-08-13Dodge & Cox7%SCHEDULE 13G
2026-08-14The WindAcre Partnership LLC8.55%SCHEDULE 13G/A
DateRecordFigureOur pageSource
October 1, 2026Leadership change: Abhijit Dubey appointed—Leadership changesSource
May 19, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Sensata Technologies Holding

At 5% or more5
Filings11
Latest filing2026-08-14

Sensata Technologies Holding has 11 Schedule 13D or 13G filings on record since 2025-08-14. 5 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Janus Henderson Group Plc6.9%10,059,585SCHEDULE 13G/A, 2025-11-142025-09-30
T. Rowe Price Associates, Inc.6.6%9,526,046SCHEDULE 13G/A, 2026-08-142026-06-30
Vanguard Portfolio Management5.35%7,803,930SCHEDULE 13G, 2026-04-292026-03-31
Vanguard Capital Management5.25%7,657,955SCHEDULE 13G, 2026-04-302026-03-31
Dimensional Fund Advisors LP5.1%7,391,230SCHEDULE 13G, 2026-04-092026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Artisan Partners Asset Management Inc.0%SCHEDULE 13G/A, 2026-08-132026-06-30
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
T. Rowe Price Associates, Inc.9,492,53109,526,0460SCHEDULE 13G/A, 2026-08-14
Vanguard Capital Management1,117,11007,657,9550SCHEDULE 13G, 2026-04-30

The latest filing identifies Sensata Technologies Holding by CUSIP G8060N102 and gives its principal executive office as INTERFACE HOUSE, INTERFACE BUSINESS PK, BINCKNOLL LN, ROYAL WOOTTON BASSETT, SWINDON (SCHEDULE 13G/A, 2026-08-14).

FiledHolderPercentFiling
2025-08-14T. Rowe Price Associates, Inc.6.8%SCHEDULE 13G/A
2025-08-14Janus Henderson Group Plc6.8%SCHEDULE 13G/A
2025-11-14Janus Henderson Group Plc6.9%SCHEDULE 13G/A
2026-02-17T. Rowe Price Associates, Inc.5.3%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-09Dimensional Fund Advisors LP5.1%SCHEDULE 13G
2026-04-29Vanguard Portfolio Management5.35%SCHEDULE 13G
2026-04-30Vanguard Capital Management5.25%SCHEDULE 13G
2026-05-13Artisan Partners Asset Management Inc.5.1%SCHEDULE 13G/A
2026-08-13Artisan Partners Asset Management Inc.0%SCHEDULE 13G/A
2026-08-14T. Rowe Price Associates, Inc.6.6%SCHEDULE 13G/A

Stereotaxis, Inc.

At 5% or more1
Filings2
Latest filing2026-08-19

Stereotaxis, Inc. has 2 Schedule 13D or 13G filings on record since 2026-05-15. 1 holder's latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Daniel Louis Kaufman5.9%5,956,714SCHEDULE 13G, 2026-08-192026-08-12
Lagoda Investment Management, L.P.4.5%4,350,400SCHEDULE 13G/A, 2026-05-152026-03-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Daniel Louis Kaufman5,956,71405,956,7140SCHEDULE 13G, 2026-08-19
Lagoda Investment Management, L.P.4,350,40004,350,4000SCHEDULE 13G/A, 2026-05-15

The latest filing identifies Stereotaxis, Inc. by CUSIP 85916J409 and gives its principal executive office as 710 N TUCKER BLVD, STE 110, ST.LOUIS, MO 63101 (SCHEDULE 13G, 2026-08-19).

5.9%, based on 100,202,178 shares of Common Stock outstanding as of July 31, 2026, as disclosed in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026, filed with the SEC on August 12, 2026.Daniel Louis Kaufman, SCHEDULE 13G, 2026-08-19
FiledHolderPercentFiling
2026-05-15Lagoda Investment Management, L.P.4.5%SCHEDULE 13G/A
2026-08-19Daniel Louis Kaufman5.9%SCHEDULE 13G

Tandem Diabetes Care, Inc.

At 5% or more3
Filings8
Latest filing2026-11-09

Tandem Diabetes Care, Inc. has 8 Schedule 13D or 13G filings on record since 2025-11-13. 3 holders' latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Portfolio Management5.91%4,052,274SCHEDULE 13G, 2026-04-292026-03-31
The Goldman Sachs Group, Inc.5.9%4,091,935SCHEDULE 13G, 2026-11-092026-09-30
Vanguard Capital Management5.18%3,553,772SCHEDULE 13G, 2026-04-302026-03-31
ArrowMark Colorado Holdings, LLC4.26%2,889,691SCHEDULE 13G/A, 2026-02-172025-12-31
Voya Financial, Inc.0.2%149,088SCHEDULE 13G/A, 2026-08-062026-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Portfolio Management58,94104,052,2740SCHEDULE 13G, 2026-04-29
The Goldman Sachs Group, Inc.04,082,85904,082,936SCHEDULE 13G, 2026-11-09
Goldman Sachs & Co. LLC04,082,85904,082,936SCHEDULE 13G, 2026-11-09
Vanguard Capital Management514,85303,553,7720SCHEDULE 13G, 2026-04-30
Voya Financial, Inc.149,0880149,0880SCHEDULE 13G/A, 2026-08-06

The latest filing identifies Tandem Diabetes Care, Inc. by CUSIP 875372203 and gives its principal executive office as 12400 HIGH BLUFF DR, SAN DIEGO (SCHEDULE 13G, 2026-11-09).

FiledHolderPercentFiling
2025-11-13ArrowMark Colorado Holdings, LLC5.46%SCHEDULE 13G
2026-02-17ArrowMark Colorado Holdings, LLC4.26%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management5.91%SCHEDULE 13G
2026-04-30Vanguard Capital Management5.18%SCHEDULE 13G
2026-05-05Voya Financial, Inc.6.3%SCHEDULE 13G
2026-08-06Voya Financial, Inc.0.2%SCHEDULE 13G/A
2026-11-09The Goldman Sachs Group, Inc.5.9%SCHEDULE 13G

Utah Medical Products Inc

At 5% or more4
Filings8
Latest filing2026-08-14

Utah Medical Products Inc has 8 Schedule 13D or 13G filings on record since 2025-07-15. 4 holders' latest filing reports 5% or more of common shares. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Brandes Investment Partners, LP14.9%475,158SCHEDULE 13G/A, 2026-08-142026-06-30
Dimensional Fund Advisors LP6.1%197,466SCHEDULE 13G/A, 2025-07-152025-06-30
Renaissance Technologies LLC5.52%175,814SCHEDULE 13G/A, 2026-08-132026-06-30
BlackRock, Inc.5.3%172,684SCHEDULE 13G, 2025-07-172025-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Brandes Investment Partners, LP0435,1110475,158SCHEDULE 13G/A, 2026-08-14
Datum One Series Trust0218,6810218,681SCHEDULE 13G/A, 2026-08-14
Renaissance Technologies LLC175,8140175,8140SCHEDULE 13G/A, 2026-08-13
Renaissance Technologies Holdings Corporation175,8140175,8140SCHEDULE 13G/A, 2026-08-13
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Utah Medical Products Inc by CUSIP 917488108 and gives its principal executive office as 7043 S 300 WEST, MIDVALE, UT 84047-1048 (SCHEDULE 13G/A, 2026-08-14).

FiledHolderPercentFiling
2025-07-15Dimensional Fund Advisors LP6.1%SCHEDULE 13G/A
2025-07-17BlackRock, Inc.5.3%SCHEDULE 13G
2025-08-12Brandes Investment Partners, LP8.4%SCHEDULE 13G/A
2025-09-05Brandes Investment Partners, LP10.4%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-05-14Brandes Investment Partners, LP14.1%SCHEDULE 13G/A
2026-08-13Renaissance Technologies LLC5.52%SCHEDULE 13G/A
2026-08-14Brandes Investment Partners, LP14.9%SCHEDULE 13G/A

Veralto Corp

At 5% or more3
Filings4
Latest filing2026-08-14

Veralto Corp has 4 Schedule 13D or 13G filings on record since 2026-03-27. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.8.5%20,884,996SCHEDULE 13G/A, 2026-07-302026-06-30
Vanguard Capital Management7.39%18,153,412SCHEDULE 13G, 2026-04-302026-03-31
T. Rowe Price Investment Management, Inc.5.6%13,722,619SCHEDULE 13G, 2026-08-142026-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.19,179,723020,884,9960SCHEDULE 13G/A, 2026-07-30
Vanguard Capital Management2,446,963018,153,4120SCHEDULE 13G, 2026-04-30
T. Rowe Price Investment Management, Inc.13,257,448013,722,6190SCHEDULE 13G, 2026-08-14
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Veralto Corp by CUSIP 92338C103 and gives its principal executive office as 225 WYMAN ST., SUITE 250, WALTHAM, MA 02451 (SCHEDULE 13G, 2026-08-14).

FiledHolderPercentFiling
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management7.39%SCHEDULE 13G
2026-07-30BlackRock, Inc.8.5%SCHEDULE 13G/A
2026-08-14T. Rowe Price Investment Management, Inc.5.6%SCHEDULE 13G

Warby Parker Inc.

At 5% or more6
Filings12
Latest filing2026-08-14

Warby Parker Inc. has 12 Schedule 13D or 13G filings on record since 2025-08-06. 6 holders' latest filing reports 5% or more of class a common stock, par value $0.0001 per share ("class a common").. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Fmr LLC15%15,858,909SCHEDULE 13G/A, 2025-12-052025-11-28
BlackRock, Inc.14%15,035,134SCHEDULE 13G/A, 2026-07-082026-06-30
Jpmorgan Chase & Co10.2%10,986,122SCHEDULE 13G/A, 2026-06-042026-05-29
Blumenthal Neil Harris7.2%8,245,050SCHEDULE 13G/A, 2026-08-142026-06-30
Durable Capital Partners LP6.9%7,310,605SCHEDULE 13G/A, 2026-02-172025-12-31
Vanguard Portfolio Management5.07%5,417,963SCHEDULE 13G, 2026-04-292026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.14,861,698015,035,1340SCHEDULE 13G/A, 2026-07-08
Jpmorgan Chase & Co10,745,8067410,972,49612,573SCHEDULE 13G/A, 2026-06-04
Blumenthal Neil Harris5,096,7163,148,3345,096,7163,148,334SCHEDULE 13G/A, 2026-08-14
Vanguard Portfolio Management86,41005,417,9630SCHEDULE 13G, 2026-04-29

The latest filing identifies Warby Parker Inc. by CUSIP 93403J106 and gives its principal executive office as 233 Spring Street, 6th Floor East, New York, NY 10013 (SCHEDULE 13G/A, 2026-08-14).

FiledHolderPercentFiling
2025-08-06Fmr LLC6.6%SCHEDULE 13G
2025-10-24Jpmorgan Chase & Co.6.9%SCHEDULE 13G
2025-11-05Fmr LLC8.8%SCHEDULE 13G/A
2025-11-14Durable Capital Partners LP8.3%SCHEDULE 13G/A
2025-12-05Fmr LLC15%SCHEDULE 13G/A
2026-01-23Jpmorgan Chase & Co.9.1%SCHEDULE 13G/A
2026-02-17Durable Capital Partners LP6.9%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management5.07%SCHEDULE 13G
2026-06-04Jpmorgan Chase & Co10.2%SCHEDULE 13G/A
2026-07-08BlackRock, Inc.14%SCHEDULE 13G/A
2026-08-14Blumenthal Neil Harris7.2%SCHEDULE 13G/A

West Pharmaceutical Svcs Inc

At 5% or more3
Filings6
Latest filing2026-11-05

West Pharmaceutical Svcs Inc has 6 Schedule 13D or 13G filings on record since 2025-10-31. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Fmr LLC8.5%5,962,738SCHEDULE 13G/A, 2026-11-052026-09-30
Vanguard Capital Management7.48%5,397,791SCHEDULE 13G, 2026-04-302026-03-31
Vanguard Portfolio Management5.69%4,102,674SCHEDULE 13G, 2026-04-292026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Fmr LLC5,665,98005,962,7380SCHEDULE 13G/A, 2026-11-05
Abigail P. Johnson005,962,7380SCHEDULE 13G/A, 2026-11-05
Vanguard Capital Management714,50505,397,7910SCHEDULE 13G, 2026-04-30
Vanguard Portfolio Management8,66504,102,6740SCHEDULE 13G, 2026-04-29
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies West Pharmaceutical Svcs Inc by CUSIP 955306105 and gives its principal executive office as 530 HERMAN O. WEST DRIVE, EXTON, PA 19341 (SCHEDULE 13G/A, 2026-11-05).

FiledHolderPercentFiling
2025-10-31The Vanguard Group13.49%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management5.69%SCHEDULE 13G
2026-04-30Vanguard Capital Management7.48%SCHEDULE 13G
2026-08-06Fmr LLC5%SCHEDULE 13G
2026-11-05Fmr LLC8.5%SCHEDULE 13G/A
DateRecordFigureOur pageSource
June 1, 2026Leadership change: Eric M. Green departs, Chief Executive Officer, and 2 more—Leadership changesSource

Zimmer Biomet Holdings, Inc.

At 5% or more4
Filings7
Latest filing2026-08-13

Zimmer Biomet Holdings, Inc. has 7 Schedule 13D or 13G filings on record since 2025-08-13. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Dodge & Cox12.5%24,124,735SCHEDULE 13G/A, 2026-08-132026-06-30
Vanguard Capital Management7.54%14,767,527SCHEDULE 13G, 2026-04-302026-03-31
Capital International Investors6.4%12,438,366SCHEDULE 13G, 2026-08-122026-06-30
Harris Associates L P6.2%12,264,703SCHEDULE 13G, 2026-02-172025-12-31
T. Rowe Price Associates, Inc.4.1%7,997,806SCHEDULE 13G/A, 2026-05-152026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Dodge & Cox22,808,935024,124,7350SCHEDULE 13G/A, 2026-08-13
Vanguard Capital Management1,974,115014,767,5270SCHEDULE 13G, 2026-04-30
Capital International Investors12,279,364012,438,3660SCHEDULE 13G, 2026-08-12
T. Rowe Price Associates, Inc.7,523,34207,997,8060SCHEDULE 13G/A, 2026-05-15

The latest filing identifies Zimmer Biomet Holdings, Inc. by CUSIP 98956P102 and gives its principal executive office as 345 East Main Street, Warsaw, IN 46580 (SCHEDULE 13G/A, 2026-08-13).

FiledHolderPercentFiling
2025-08-13Dodge & Cox11.2%SCHEDULE 13G/A
2026-02-17Harris Associates L P6.2%SCHEDULE 13G
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management7.54%SCHEDULE 13G
2026-05-15T. Rowe Price Associates, Inc.4.1%SCHEDULE 13G/A
2026-08-12Capital International Investors6.4%SCHEDULE 13G
2026-08-13Dodge & Cox12.5%SCHEDULE 13G/A
DateRecordFigureOur pageSource
September 8, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
April 28, 2026Leadership change: Suketu Upadhyay departs, Chief Financial Officer, and 1 more—Leadership changesSource

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All 5%+ stakes

RSS